Astellas Pharma Inc (ALPMF)
Market Closed
12 Jun, 20:00
$
14. 96
+1.21
+8.8%
$
26.05B Market Cap
152.62 P/E Ratio
78% Div Yield
63,600 Volume
0.14 Eps
$ 13.75
Previous Close Want to track ALPMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astellas Pharma Inc (ALPMF) Statistics
Valuation metrics
Market Cap 26.05B
Enterprise value 4.12T
Trailing P/E (ttm) 13.18
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 1.79
Price/Book (mrq) 2.1
Enterprise Value/Revenue 1.93
Enterprise Value/EBITDA 6.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.6K
Average volume (90 days) 2.72K
Price summary
52-Week low 9.34
52-Week high 17.85
Beta -
50-Day moving average 14.44
200-Day moving average 14.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 78
Trailing annual dividend yield 0.0364%
5-Year annual dividend yield -
Payout ratio 0.47
Dividend Date 3 Jun 2025
Ex-Dividend Date 31 Mar 2025
Last split factor 5:1
Last split Date 27 Mar 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.19%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1,191.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 162.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 156.81
Total debt (mrq) -
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 1.17%
Book value per share (mrq) 1,019.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
